Xiling Lab

Company Deals

Xiling Lab Raises RMB 100 Million for ADC Development and IND Filing

Fineline Cube Nov 25, 2022

Xiling Lab, a Chengdu-based drug developer specializing in catalytic synthesis technology, has reportedly raised close...

Company Deals

Sunshine Guojian Pharmaceutical Signs Licensing Deal for Cipterbin ADC Development

Fineline Cube Jun 24, 2022

China-based Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a subsidiary of 3SBio Inc. (HKG: 1530), has...

Company Drug

AbbVie’s SKYRIZI Wins FDA Approval for Pediatric Psoriasis, Expanding IL-23 Blocker to Children Six and Older

Company Drug

Akeso Biopharma Ships First Batch of Gumokimab for Psoriasis Following NMPA Approval

Company Drug

Eli Lilly’s Jaypirca Wins CHMP Recommendation for All-Line CLL Treatment Regardless of Prior BTK Inhibitor Use

Company Deals

Fosun Pharmaceutical Approves Hong Kong IPO Spin-Off of Vaccine Subsidiary Fosun Adgenvax